Earth Science Tech, Inc. (ETST) Investor Relations Kit
Market Opportunity Earth Science Tech is poised in a variety of sectors offering tremendous growth. Through its subsidiary, Earth Science Pharmaceutical, Inc., the company is researching and bringing to market testing tools and vac- cines to detect and treat sexually transmitted illnesses. The company’s offerings will meet critical demands, with the global market for STI diagnostic testing devices expected to reach over $200 billion by 2022 ( http://nnw.fm/py6Dm ). The World Health Organization estimates that there are approximately 357 million new sexually transmitted infections each year (http://nnw.fm/kojY3 ) and recommends that all pregnant women be tested for chlamydia. This has further expanded the already large testing market, creating a need for products such as ETST’s MSN-2, which is rounding clinical trials.